IR-Med, Inc.

IRME OTC CIK: 0001839133

Company Information

Industry Electromedical & Electrotherapeutic Apparatus
SIC Code 3845
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation NV
Business Address C/O ABOUDI LEGAL GROUP PLLC, 745 5TH AVE, NEW YORK, NY, 10151
Mailing Address C/O ABOUDI LEGAL GROUP PLLC, 745 5TH AVE, NEW YORK, NY, 10151
Phone 6467684285
Fiscal Year End 1231
EIN 844516398

Financial Overview

FY2024

-$1.90M
Net Income
$999K
Total Assets
$2.59M
Stockholders' Equity
$767K
Cash & Equivalents

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events February 5, 2026 View on SEC
8-K Current report of material events December 12, 2025 View on SEC
8-K Current report of material events September 22, 2025 View on SEC
8-K Current report of material events September 11, 2025 View on SEC
8-K Current report of material events September 3, 2025 View on SEC
10-Q Quarterly financial report August 14, 2025 View on SEC
8-K Current report of material events August 7, 2025 View on SEC
8-K Current report of material events July 29, 2025 View on SEC
8-K Current report of material events July 11, 2025 View on SEC
8-K Current report of material events June 10, 2025 View on SEC

Material Events

8-K Financial Distress December 12, 2025
High Impact
  • IR-Med, Inc. is facing severe financial difficulties and a significant cash crunch.
  • The CEO and CFO compensation has been changed from fixed monthly salaries to hourly rates to conserve cash, effective December 1, 2025.
View Analysis

Related Companies

Companies in the same industry (SIC: 3845)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.